NO ALTERATIONS IN THE 5-HT1A-MEDIATED INHIBITION OF FORSKOLIN-STIMULATED ADENYLATE-CYCLASE ACTIVITY IN THE HIPPOCAMPAL MEMBRANES FROM RATS CHRONICALLY TREATED WITH LITHIUM OR ANTIDEPRESSANTS

被引:19
作者
ODAGAKI, Y
KOYAMA, T
YAMASHITA, I
机构
[1] Department of Psychiatry and Neurology, Hokkaido University School of Medicine, Sapporo
关键词
LITHIUM; IMIPRAMINE; DESIPRAMINE; TRANYLCYPROMINE; 5-HT1A RECEPTORS; ADENYLATE CYCLASE; HIPPOCAMPUS;
D O I
10.1007/BF01250570
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In order to determine the relevance of 5-HT1A-related signal transduction in the mode of action of lithium and antidepressants, the effects of long-term treatment with these drugs on the 5-HT1A -mediated inhibition of forskolin-stimulated adenylate cyclase activity were investigated in the rat hippocampal membranes. Chronic administration of antidepressants altered neither the [H-3]8-hydroxy-2-(di-n-propylamino)tetralin ([H-3]8-OH-DPAT) binding sites nor the inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT. Long-term treatment with lithium did not affect the inhibitory effect of 5-HT on the forskolin-stimulated adenylate cyclase activity, either. Neither the stimulation by forskolin nor the inhibition by guanyl-5' -ylimidodiphosphate (Gpp(NH)p) of adenylate cyclase activity was not influenced by lithium treatment, suggesting that lithium has no effects on the components of adenylate cyclase system distal to the 5-HT1A receptors. These results indicate that the 5-HT1A -mediated neural transmissio has not such an important relevance in the mechanisms of action of lithium or antidepressants.
引用
收藏
页码:85 / 96
页数:12
相关论文
共 33 条
[1]  
AMSTERDAM JD, 1987, CURR THER RES CLIN E, V41, P185
[2]   DIFFERENTIAL EFFECT OF SUBCHRONIC TREATMENT WITH VARIOUS NEUROLEPTIC AGENTS ON SEROTONIN2 RECEPTORS IN RAT CEREBRAL-CORTEX [J].
ANDREE, TH ;
MIKUNI, M ;
TONG, CY ;
KOENIG, JI ;
MELTZER, HY .
JOURNAL OF NEUROCHEMISTRY, 1986, 46 (01) :191-197
[3]   LITHIUM INHIBITS ADRENERGIC AND CHOLINERGIC INCREASES IN GTP BINDING IN RAT CORTEX [J].
AVISSAR, S ;
SCHREIBER, G ;
DANON, A ;
BELMAKER, RH .
NATURE, 1988, 331 (6155) :440-442
[4]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[5]  
DEVIVO M, 1986, J PHARMACOL EXP THER, V238, P248
[6]   STIMULATION AND INHIBITION OF ADENYLYL CYCLASE BY DISTINCT 5-HYDROXYTRYPTAMINE RECEPTORS [J].
DEVIVO, M ;
MAAYANI, S .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1551-1558
[7]  
GOODWIN FV, 1983, BR J CLIN PHARM, V15, P393
[8]  
GOODWIN GM, 1989, PROG NEURO-PSYCHOPH, V13, P445
[9]   5-HYDROXYTRYPTAMINE1A RECEPTORS ARE LINKED TO A GI-ADENYLATE CYCLASE COMPLEX IN RAT HIPPOCAMPUS [J].
HARRINGTON, MA ;
OKSENBERG, D ;
PEROUTKA, SJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (01) :95-98
[10]   LONG-TERM LITHIUM TREATMENT CAUSES SEROTONIN RECEPTOR DOWN-REGULATION VIA SEROTONERGIC PRESYNAPSES IN RAT-BRAIN [J].
HOTTA, I ;
YAMAWAKI, S ;
SEGAWA, T .
NEUROPSYCHOBIOLOGY, 1986, 16 (01) :19-26